FDA Updates Guidelines for Sports Nutrition Supplement Labels: Chinese Translations Must Be FDA-Certified

On April 14, 2026, the U.S. Food and Drug Administration (FDA) released a draft revision to its Guidelines for Sports Nutrition Supplement Labels, introducing a new requirement for imported products with Chinese labels. The FDA now mandates that Chinese translations must be completed by an FDA-recognized certified translation agency and submitted for archiving. This change will impact Chinese sports nutrition manufacturers and OEM brands exporting to the U.S., requiring adjustments to compliance processes and market entry timelines.

Event Overview

The FDA's updated draft guidelines specify that all imported sports nutrition supplements featuring Chinese labels must have their translations verified and filed by an FDA-approved translation provider. This marks the first time the FDA has explicitly addressed language requirements for non-English labels in this sector. The revision aims to enhance label accuracy and consumer safety but introduces additional compliance steps for exporters.

Industries Affected

Chinese Sports Nutrition Manufacturers

Manufacturers producing supplements for U.S. export will need to engage FDA-certified translation services for their Chinese labels. This may increase production lead times and compliance costs, particularly for OEM brands serving multiple markets.

U.S. Importers and Distributors

Importers working with Chinese suppliers must now verify that label translations meet FDA standards before products enter the U.S. market. Delays in translation approval could disrupt supply chains and inventory planning.

Translation and Compliance Service Providers

The new rule creates opportunities for translation agencies specializing in FDA compliance. However, providers will need to undergo FDA certification to qualify for this niche market.

Key Considerations and Recommended Actions

Monitor FDA Certification Updates

Companies should track the FDA's list of approved translation providers as it becomes available. Early engagement with certified agencies will help streamline future compliance.

Review Labeling Workflows

Exporters need to build additional time into their production schedules for translation certification. Current label approval processes may require 4-6 weeks of additional lead time.

Strengthen Importer-Supplier Coordination

Brands relying on Chinese manufacturing should establish clear communication channels with suppliers regarding label requirements. Joint compliance checklists can help prevent shipment delays.

Industry Perspective

From an industry standpoint, this move signals the FDA's increasing focus on multilingual label accuracy. While currently limited to sports nutrition supplements, the policy could expand to other supplement categories with non-English labeling. The requirement emphasizes the growing importance of standardized compliance processes in global supplement trade.

Observers note that the draft guidelines represent an intermediate step rather than final policy. The FDA typically allows for public comment periods before finalizing such changes, suggesting potential adjustments to implementation details.

Conclusion

The FDA's proposed label translation requirements reflect evolving standards for imported supplements in multilingual markets. While adding complexity to export processes, the changes ultimately aim to protect consumers through improved label transparency. Industry participants should view this development as part of broader regulatory trends toward supply chain accountability in global commerce.

At this stage, businesses would be prudent to treat the draft guidelines as a preview of coming compliance expectations rather than immediate operational directives. Proactive preparation through supply chain reviews and compliance partner identification will position companies favorably as the policy develops.

Information Sources

• U.S. FDA Draft Guidance: Labeling of Sports Nutrition Supplements (April 14, 2026)
• Regulatory update pending final publication in the Federal Register